Matches in SemOpenAlex for { <https://semopenalex.org/work/W3106422381> ?p ?o ?g. }
- W3106422381 endingPage "3356" @default.
- W3106422381 startingPage "3356" @default.
- W3106422381 abstract "Esophageal adenocarcinoma (EAC) is an aggressive cancer with poor prognosis and incidence is increasing rapidly in the Western world. Multi-modal treatment has improved survival outcomes but only for a minority of patients. Currently no markers have been identified to predict treatment response. This study investigated the association between clinical outcomes and pre-treatment levels of 54 serum proteins in n = 80 patients with EAC. Low tumor regression grade (TRG), corresponding to a favorable treatment response, was linked to prolonged overall survival (OS). CCL4 was higher in patients with a favorable treatment response, while Tie2 and CRP were higher in poor responders. Elevated CCL22 and CCL26 was associated with improved OS, while elevated IL-10 showed a negative association. CCL3, CCL4, IL-1α and IL-12/IL23p40 were highest in individuals with no adverse features of tumor biology, whereas levels of Tie2 and VEGF were lowest in this cohort. CCL4 was also elevated in patients with high tumor lymphocyte infiltration. Comparison of matched pre- and post-treatment serum (n = 28) showed a large reduction in VEGFC, and a concomitant increase in other cytokines, including CCL4. These data link several serum markers with clinical outcomes, highlighting an important role for immune cell trafficking in the EAC antitumor immune response." @default.
- W3106422381 created "2020-11-23" @default.
- W3106422381 creator A5000574895 @default.
- W3106422381 creator A5001091825 @default.
- W3106422381 creator A5002637452 @default.
- W3106422381 creator A5011416550 @default.
- W3106422381 creator A5016890096 @default.
- W3106422381 creator A5021037111 @default.
- W3106422381 creator A5024262881 @default.
- W3106422381 creator A5031556989 @default.
- W3106422381 creator A5033082307 @default.
- W3106422381 creator A5046200335 @default.
- W3106422381 creator A5051782915 @default.
- W3106422381 creator A5052768140 @default.
- W3106422381 creator A5055553940 @default.
- W3106422381 creator A5061083564 @default.
- W3106422381 creator A5063780851 @default.
- W3106422381 creator A5074199121 @default.
- W3106422381 creator A5076165059 @default.
- W3106422381 creator A5077170473 @default.
- W3106422381 date "2020-11-13" @default.
- W3106422381 modified "2023-09-27" @default.
- W3106422381 title "Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines" @default.
- W3106422381 cites W1564857641 @default.
- W3106422381 cites W1606124548 @default.
- W3106422381 cites W1911271782 @default.
- W3106422381 cites W1912124796 @default.
- W3106422381 cites W1952821838 @default.
- W3106422381 cites W1977468182 @default.
- W3106422381 cites W1988614578 @default.
- W3106422381 cites W1991258536 @default.
- W3106422381 cites W1995378816 @default.
- W3106422381 cites W2007327460 @default.
- W3106422381 cites W2026613554 @default.
- W3106422381 cites W2029199150 @default.
- W3106422381 cites W2029698856 @default.
- W3106422381 cites W2070655665 @default.
- W3106422381 cites W2079812570 @default.
- W3106422381 cites W2080025996 @default.
- W3106422381 cites W2105411275 @default.
- W3106422381 cites W2111674123 @default.
- W3106422381 cites W2112062992 @default.
- W3106422381 cites W2115072149 @default.
- W3106422381 cites W2119255644 @default.
- W3106422381 cites W2121546291 @default.
- W3106422381 cites W2128560067 @default.
- W3106422381 cites W2128998354 @default.
- W3106422381 cites W2129566355 @default.
- W3106422381 cites W2135752573 @default.
- W3106422381 cites W2144846148 @default.
- W3106422381 cites W2166760601 @default.
- W3106422381 cites W2300154809 @default.
- W3106422381 cites W2308754045 @default.
- W3106422381 cites W2313945592 @default.
- W3106422381 cites W2334750499 @default.
- W3106422381 cites W2336002574 @default.
- W3106422381 cites W2338880854 @default.
- W3106422381 cites W2339182230 @default.
- W3106422381 cites W2429135718 @default.
- W3106422381 cites W2527534199 @default.
- W3106422381 cites W2567257805 @default.
- W3106422381 cites W2753811612 @default.
- W3106422381 cites W2755375695 @default.
- W3106422381 cites W2759258394 @default.
- W3106422381 cites W2765514404 @default.
- W3106422381 cites W2898815261 @default.
- W3106422381 cites W2911977097 @default.
- W3106422381 cites W2914380935 @default.
- W3106422381 cites W2919257829 @default.
- W3106422381 cites W2938774982 @default.
- W3106422381 cites W2952477280 @default.
- W3106422381 cites W2966226124 @default.
- W3106422381 cites W2989721842 @default.
- W3106422381 cites W3003445183 @default.
- W3106422381 cites W3011940221 @default.
- W3106422381 cites W3040706248 @default.
- W3106422381 cites W4210685329 @default.
- W3106422381 doi "https://doi.org/10.3390/cancers12113356" @default.
- W3106422381 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7698106" @default.
- W3106422381 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33202734" @default.
- W3106422381 hasPublicationYear "2020" @default.
- W3106422381 type Work @default.
- W3106422381 sameAs 3106422381 @default.
- W3106422381 citedByCount "11" @default.
- W3106422381 countsByYear W31064223812021 @default.
- W3106422381 countsByYear W31064223812022 @default.
- W3106422381 countsByYear W31064223812023 @default.
- W3106422381 crossrefType "journal-article" @default.
- W3106422381 hasAuthorship W3106422381A5000574895 @default.
- W3106422381 hasAuthorship W3106422381A5001091825 @default.
- W3106422381 hasAuthorship W3106422381A5002637452 @default.
- W3106422381 hasAuthorship W3106422381A5011416550 @default.
- W3106422381 hasAuthorship W3106422381A5016890096 @default.
- W3106422381 hasAuthorship W3106422381A5021037111 @default.
- W3106422381 hasAuthorship W3106422381A5024262881 @default.
- W3106422381 hasAuthorship W3106422381A5031556989 @default.
- W3106422381 hasAuthorship W3106422381A5033082307 @default.
- W3106422381 hasAuthorship W3106422381A5046200335 @default.